Medical specialists from Canada tagged as investigators in clinical trials studying Idiopathic Pulmonary Fibrosis
Total 11 results
-
Christian Pineau, MDSeen in:
- Quebec, Montréal, RI-MUHC
Trials:- NCT05007340 (Principal Investigator)
-
Christopher Ryerson, MDSeen in:
- British Columbia, Vancouver, St.Paul's Hospital
Trials:- NCT04708782 (Principal Investigator)
Conditions: -
Émilie Millaire, MDSeen in:
- Quebec, Québec, CIC Mauricie inc.
- Quebec, Trois-Rivières, Centre d'investigation Clinique Mauricie
Trials:- NCT04708782 (Principal Investigator)
- NCT05943535 (Principal Investigator)
-
George Philteos, MDSeen in:
- Ontario, Ajax, Dynamic Drug Advancement Limited
- Ontario, Ajax, Dynamic Drug Advancement Ltd.
Trials:- NCT04708782 (Principal Investigator)
- NCT05032066 (Principal Investigator)
- NCT05943535 (Principal Investigator)
-
Gerard Cox, MDSeen in:
- Ontario, Hamilton, St. Joseph's Healthcare Hamilton
Trials:- NCT05032066 (Principal Investigator)
Conditions: -
Inés Colmegna, MDSeen in:
- Quebec, Montréal, RI-MUHC
- Quebec, Montréal, Research Institute - McGill University Health Centre
Trials:- NCT05236491 (Principal Investigator)
- NCT05007340 (Principal Investigator)
Conditions:- Rheumatoid Arthritis;
- Systemic Lupus Erythematosus;
- Systemic Sclerosis;
- Systemic Vasculitis;
- Immunosuppression;
- Scleroderma;
- Autoimmune Rheumatologic Disease;
- Undifferentiated Connective Tissue Diseases;
- Overlap Connective Tissue Disease;
- Rheumatic Diseases;
- Interstitial Lung Disease;
- Usual Interstitial Pneumonia;
- Nonspecific Interstitial Pneumonia;
- Rheumatic Arthritis;
- Systemic Autoimmune Disease;
- Autoimmune Myositis
-
Marco Mura, MD, PhDSeen in:
- Ontario, London, London Health Science Centre
Trials:- NCT03950583 (Principal Investigator)
- NCT02632123 (Principal Investigator)
Conditions: -
Nathan Hambly, MDSeen in:
- Ontario, Hamilton, St. Joseph's Healthcare Centre
- Ontario, Hamilton, St. Joseph's Healthcare Hamilton
Trials:- NCT04708782 (Principal Investigator)
- NCT03593759 (Principal Investigator)
-
Paul Hernandez, MDSeen in:
- Nova Scotia, Halifax, Queen Elizabeth Ii Health Sciences Centre
Trials:- NCT04708782 (Principal Investigator)
- NCT01983241 (Principal Investigator)
-
Silvia Vidal, PhDSeen in:
- Quebec, Montréal, RI-MUHC
Trials:- NCT05007340 (Principal Investigator)
-
Steeve Provencher, MDSeen in:
- Quebec, Institut Universitaire de Cardiologie et de Pneumologie de Quebec-Universite
- Quebec, Quebec City, IUCPQ-UL
- Quebec, Québec, Institut universitaire de Cardiologie et de Pneumologie de Quebec
Trials:- NCT04708782 (Principal Investigator)
- NCT03626688 (Principal Investigator)
- NCT03782818 (Principal Investigator)
Conditions:- Idiopathic Pulmonary Fibrosis;
- Interstitial Lung Disease;
- Cardiovascular Diseases;
- Vascular Diseases;
- Lung Diseases;
- Hypertension;
- Connective Tissue Diseases;
- Pulmonary Arterial Hypertension;
- Familial Primary Pulmonary Hypertension;
- Hypertension, Pulmonary;
- Pulmonary Hypertension;
- PAH;
- Respiratory Tract Disease
Clinical Trials on Idiopathic Pulmonary Fibrosis
-
St. Antonius HospitalZonMw: The Netherlands Organisation for Health Research and Development; Boeringer...RecruitingPulmonary Fibrosis Idiopathic FamilialNetherlands
-
Wake Forest University Health SciencesMayo Clinic; The University of Texas Health Science Center at San AntonioCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Sheba Medical CenterUnknownIDIOPATHIC PULMONARY FIBROSISIsrael
-
Theravance BiopharmaTerminatedIdiopathic Pulmonary Fibrosis (IPF)United Kingdom
-
University of California, San FranciscoCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
BiogenCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Liminal BioSciences Ltd.CompletedIdiopathic Pulmonary Fibrosis (IPF)Canada
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary Fibrosis (IPF)United States
-
Angion Biomedica CorpNot yet recruitingIdiopathic Pulmonary Fibrosis (IPF)
-
Xfibra, Inc.Not yet recruitingIdiopathic Pulmonary Fibrosis (IPF)